Treatment of community-acquired pneumonia in immunocompromised adults: A consensus statement regarding initial strategies
pneumonia; community-acquired pneumonia; immunocompromised
Background Community-acquired pneumonia (CAP) guidelines have improved the treatment and outcomes of patients with CAP, primarily by standardization of initial empirical therapy. But current society-published guidelines exclude immunocompromised patients.
Ramirez JA;Musher DM;Evans SE;Dela CC;Crothers KA;Hage CA;Aliberti S;Anzueto A;Arancibia F;Arnold F;Azoulay E;Blasi F;Bordon J;Burdette S;Cao B;Cavallazzi R;Chalmers J;Charles P;Chastre J;Claessens Y-E;Dean N;Duval X;Fartoukh M;Feldman C;File T;Froes F;Furmanek S;Gnoni M;Lopardo G;Luna C;Maruyama T;Menendez R;Metersky M;Mildvan D;Mortensen E;Niederman MS;Pletz M;Rello J;Restrepo MI;Shindo Y;Torres A;Waterer G;Webb B;Welte T;Witzenrath M;Wunderink R
Chest
2020
2020-11-01
journalArticle
<a href="http://doi.org/10.1016/j.chest.2020.05.598" target="_blank" rel="noreferrer noopener">10.1016/j.chest.2020.05.598</a>
Management of community-acquired pneumonia in immunocompromised adults: a consensus statement regarding initial strategies".
BACKGROUND: Community-acquired pneumonia (CAP) guidelines have improved the management and outcomes of patients with CAP, primarily by standardization of initial empiric therapy. But current society-published guidelines exclude immunocompromised patients. RESEARCH QUESTION: There is no concensus regarding the initial management of immunocompromised patients with suspected CAP. STUDY DESIGN AND METHODS: This consensus document was created by a multidisciplinary panel of 45 physicians with experience in the management of CAP in immunocompromised patients. The Delphi survey methodology was used to reach consensus. RESULTS: The panel focused on 21 questions addressing initial management strategies. The panel achieved consensus in defining the population, site of care, likely pathogens, microbiological work-up, general principles of empiric therapy, and empiric therapy for specific pathogens. INTERPRETATION: This document offer general suggestions for the initial management of the immunocompromised patient who arrives at the hospital with pneumonia.
Ramirez JA; Musher DM; Evans SE; Dela CC; Crothers KA; Hage CA; Aliberti S; Anzueto A; Arancibia F; Arnold F; Azoulay E; Blasi F; Bordon J; Burdette S; Cao B; Cavallazzi R; Chalmers J; Charles P; Chastre J; Claessens Y; Dean N; Duval X; Fartoukh M; Feldman C; File T; Froes F; Furmanek S; Gnoni M; Lopardo G; Luna C; Maruyama T; Menendez R; Metersky M; Mildvan D; Mortensen E; Niederman MS; Pletz M; Rello J; Restrepo MI; Shindo Y; Torres A; Waterer G; Webb B; Welte T; Witzenrath M; Wunderink R
Chest
2020
2020-06
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
journalArticle
<a href="http://doi.org/10.1016/j.chest.2020.05.598" target="_blank" rel="noreferrer noopener">10.1016/j.chest.2020.05.598</a>
Ethical Considerations Regarding The Administration Of Oseltamivir For Infection Control Indications - Reply
acute influenza; adults; Immunology; Infectious Diseases; Microbiology; neuraminidase inhibitor oseltamivir
Mandell L A; Wunderink R G; Anzueto A; Bartlett J G; Campbell G D; Dean N C; Dowell S F; File T M; Musher D M; Niederman M S; Torres A; Whitney C G
Clinical Infectious Diseases
2007
2007-07
Journal Article or Conference Abstract Publication
<a href="http://doi.org/10.1086/520486" target="_blank" rel="noreferrer noopener">10.1086/520486</a>